Literature DB >> 23128288

Racemic marinopyrrole B by total synthesis.

Ping Cheng1, Derrick L J Clive, Shimal Fernandopulle, Zhenhua Chen.   

Abstract

The first synthesis of marinopyrrole B, which is highly active against methicillin-resistant Staphylococcus aureus, is described. The route involved constructing a pyrrole ring on the nitrogen of a 3-bromo-4,5-dichloropyrrole by N-alkylation with a special Michael acceptor having an allylic leaving group; the second pyrrole ring was then formed by a Paal-Knorr reaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23128288     DOI: 10.1039/c2cc37110c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Marine Pyrrole Alkaloids.

Authors:  Kevin Seipp; Leander Geske; Till Opatz
Journal:  Mar Drugs       Date:  2021-09-10       Impact factor: 5.118

2.  Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II).

Authors:  Chunwei Cheng; Yan Liu; Hao Song; Lili Pan; Jerry Li; Yong Qin; Rongshi Li
Journal:  Mar Drugs       Date:  2013-08-15       Impact factor: 5.118

3.  Cyclic marinopyrrole derivatives as disruptors of Mcl-1 and Bcl-x(L) binding to Bim.

Authors:  Chunwei Cheng; Yan Liu; Maria E Balasis; Nicholas L Simmons; Jerry Li; Hao Song; Lili Pan; Yong Qin; K C Nicolaou; Said M Sebti; Rongshi Li
Journal:  Mar Drugs       Date:  2014-03-07       Impact factor: 5.118

4.  Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (III).

Authors:  Yan Liu; Nina M Haste; Wdee Thienphrapa; Jerry Li; Victor Nizet; Mary Hensler; Rongshi Li
Journal:  Mar Drugs       Date:  2014-04-30       Impact factor: 5.118

5.  Marinopyrrole derivatives with sulfide spacers as selective disruptors of Mcl-1 binding to pro-apoptotic protein Bim.

Authors:  Chunwei Cheng; Yan Liu; Maria E Balasis; Thomas P Garner; Jerry Li; Nicholas L Simmons; Norbert Berndt; Hao Song; Lili Pan; Yong Qin; K C Nicolaou; Evripidis Gavathiotis; Said M Sebti; Rongshi Li
Journal:  Mar Drugs       Date:  2014-07-29       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.